Edition:
India

Halozyme Therapeutics Inc (HALO.OQ)

HALO.OQ on NASDAQ Stock Exchange Global Select Market

16.82USD
19 Feb 2019
Change (% chg)

$-0.22 (-1.29%)
Prev Close
$17.04
Open
$17.06
Day's High
$17.17
Day's Low
$16.74
Volume
191,181
Avg. Vol
291,041
52-wk High
$21.47
52-wk Low
$13.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 25.56 -0.193
Jun '18 35.20 -0.159
Mar '18 30.87 -0.192
FY 2017 Dec '17 189.56 0.813
Sep '17 63.73 0.019
Jun '17 33.75 -0.230
Mar '17 29.57 -0.256
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 5 51.05 81.00 32.35 39.00
Quarter Ending Jun-19 5 45.98 56.04 36.07 41.40
Year Ending Dec-19 8 168.78 206.00 129.00 183.63
Earnings (per share)
Quarter Ending Mar-19 8 -0.13 0.13 -0.22 -0.14
Quarter Ending Jun-19 8 -0.15 -0.09 -0.24 -0.14
Year Ending Dec-19 11 -0.63 -0.46 -0.83 -0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 8.61 38.85 21.20
EPS (TTM) % -216.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Halozyme Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.89 26.38 99 --
13 Week 31.70 25.28 99 --
26 Week 35.76 25.44 99 --
52 Week 41.58 20.00 99 --
YTD 73.68 52.53 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.75%
# of Holders: 275
Total Shares Held: 126,854,858
3 Mo. Net Change: -2,081,589
# New Positions: 32
# Closed Positions: 35
# Increased Positions: 119
# Reduced Positions: 110
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.